Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Hennessee Hedge Fund Index increased +2.46% in February (+2.18% YTD)

Monday, March 17, 2014
Opalesque Industry Update - Hennessee Group LLC announced today that the Hennessee Hedge Fund Index increased +2.46% in February (+2.18% YTD), while the S&P 500 gained +4.31% (+0.60% YTD), the Dow Jones Industrial Average rose +3.97% (-1.54% YTD), and the NASDAQ Composite Index jumped +4.98% (+3.15% YTD). Bonds were positive on the month, as the Barclays Aggregate Bond Index increased +0.53% (+2.02% YTD).

"The Hennessee Hedge Fund Index was up +2.46% for February with the top three strategies for the month being Healthcare and Biotech (+4.14%), Distressed (+3.72%) and International (+3.29%).” commented Charles Gradante, Co-Founder of Hennessee Group LLC. "The bottom three strategies for the month were Short Biased (-2.34%), Market Neutral (-0.02%) and Convertible Arbitrage (+0.19%).”

"Risk assets reversed course again in February as volatility, measured by the VIX, subsided and market enthusiasm was restored.” commented Charles Gradante, Co-Founder of Hennessee Group LLC. "Investors stepped back into the market after January’s selloff and shrugged off disappointing European PMI data, a continued decrease in bank lending and emerging market tensions.”

Equity long/short hedge funds were positive in February, as the Hennessee Long/Short Equity Index gained +2.81% (+3.13% YTD). The best performing sectors were consumer staples (+6.69%), health care (+6.09%), and consumer discretionary (+5.95%), while underperforming sectors were energy (-1.04%), telecommunication services (+2.80%) and information technology (+2.94%). U.S. stocks reached record highs during February despite weak macro economic data.

“Managers are not changing their net long bias as there is no competition for equities and stock buybacks continue reducing supply.” reported Charles Gradante.

“Managers continue to maintain bullish reporting to Hennessee that ‘bull markets don’t die of old age. Bull markets end with a recession, excessive valuations or a fat tail event’.” reported Lee Hennessee, Co-Founder of Hennessee Group LLC.

The Hennessee Arbitrage/Event Driven Index rose +1.83% in February (+2.50% YTD). The Barclays Aggregate Bond Index gained +0.53% (+2.02% YTD) as interest rates were modestly lower in February. High yield increased as the Merrill Lynch High Yield Master II Index increased +2.00% in February (+2.76% YTD). High yield spreads decreased rather dramatically, losing 40 basis points to end the month 381 basis points over treasuries. The Hennessee Distressed Index jumped +3.72% in February (+4.54% YTD) on the heels of a strong January return for the index. The Hennessee Merger Arbitrage Index gained +1.81% in February (+2.04% YTD) as the environment for M&A remained strong. The Hennessee Convertible Arbitrage Index was modestly higher, gaining +0.19% in February (+1.98% YTD).

The Hennessee Global/Macro Index gained 2.53% in February (+0.47% YTD). The Dow Jones UBS Commodity Index reversed course and jumped +6.23% (+6.54% YTD), while the MSCI ACWI Index gained +4.65% (+0.39% YTD) and the MSCI EAFE Index gained +5.35% (+1.06% YTD). The Hennessee International Index gained +3.29% in February (+0.33%). Large gains in Ireland, Denmark, Greece, Portugal and Finland far outweighed losses in Japan, Russia, Hungary and Mexico. Emerging markets were mostly positive for February, as the MSCI Emerging Market Index rose +3.19% (-3.62% YTD), while, the Hennessee Emerging Market Index gained +2.14% (-0.20% YTD). Emerging markets continued to underperform developed markets for the year as investors continue to see considerable growth and inflation risks in these markets. The Hennessee Macro Index rose +2.65% for the month of February (+0.83% YTD).

Fixed income managers were modestly positive in February as bond yields were relatively flat for the month with the 10-Year U.S. Treasury ending the month at 2.66%, down 1 basis point from 2.67% in January. Commodities were strong for the month, with gold rising +6.58%, silver jumping +10.61% and palladium gaining +5.55% for the month. The U.S. Dollar was relatively weak against major currencies, losing over -0.50% versus the Euro, -0.88% versus the British Pound, -0.25% versus the Japanese Yen and -0.39% versus the Canadian Dollar. Oil rose in February, with WTI gaining +5.23% and European Brent Blend Crude rising +2.18%. Natural gas continued to surge, jumping +23.46% for the month.

Hennessee Group

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for